Suppr超能文献

兴奋剂与肺部:文献综述。

Stimulants and the lung : review of literature.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, University of California at Davis, School of Medicine and VA Northern California Health Care System, 4150 V Street, Suite 3400, Sacramento, CA, 95817, USA,

出版信息

Clin Rev Allergy Immunol. 2014 Feb;46(1):82-100. doi: 10.1007/s12016-013-8376-9.

Abstract

Illicit stimulants, such as cocaine, amphetamine, and their derivatives (e.g., "ecstasy"), continue to exact heavy toll on health care in both developed and developing countries. The US Department of Health and Human Service reported over one million illicit drug-related emergency department visits in 2010, which was higher than any of the six previous years. Both inhaled and intravenous forms of these substances of abuse can result in a variety of acute and chronic injuries to practically every part of the respiratory tract, leading potentially to permanent morbidities as well as fatal consequences--including but not limited to nasal septum perforation, pulmonary hypertension, pneumothorax, pneumomediastinum, interstitial lung disease, alveolar hemorrhage, reactive airway disease, pulmonary edema, pulmonary granulomatosis, infections, foreign body aspiration, infections, bronchoconstriction, and thermal injuries. Stimulants are all rapidly absorbed substances that can also significantly alter the patient's systemic acid-base balance and central nervous system, thereby leading to further respiratory compromise. Mounting evidence in the past decade has demonstrated that adulterants coinhaled with these substances (e.g., levamisole) and the metabolites of these substances (e.g., cocaethylene) are associated with specific forms of systemic and respiratory complications as well. Recent studies have also demonstrated the effects of stimulants on autoimmune-mediated injuries of the respiratory tract, such as cocaine-induced midline destructive lesions. A persistent challenge to studies involving stimulant-associated respiratory toxidromes is the high prevalence of concomitant usage of various substances by drug abusers, including tobacco smoking. Now more than ever, health care providers must be familiar with the multitude of respiratory toxidromes as well as the diverse pathophysiology related to commonly abused stimulants to provide timely diagnosis and effective treatment.

摘要

非法兴奋剂,如可卡因、安非他命及其衍生物(如“摇头丸”),继续对发达国家和发展中国家的医疗保健造成严重影响。美国卫生与公众服务部报告称,2010 年有超过 100 万例与非法药物有关的急诊就诊,高于前六年中的任何一年。这些滥用物质的吸入和静脉注射形式均可导致呼吸道几乎每个部位出现各种急性和慢性损伤,从而导致潜在的永久性病态和致命后果——包括但不限于鼻中隔穿孔、肺动脉高压、气胸、纵隔气肿、间质性肺病、肺泡出血、反应性气道疾病、肺水肿、肺肉芽肿病、感染、异物吸入、感染、支气管收缩和热损伤。兴奋剂都是迅速被吸收的物质,也会显著改变患者的全身酸碱平衡和中枢神经系统,从而导致进一步的呼吸恶化。过去十年中的大量证据表明,与这些物质共吸入的掺杂物(例如左旋咪唑)和这些物质的代谢物(例如可卡因乙基醚)与特定形式的全身和呼吸道并发症有关。最近的研究还表明兴奋剂对呼吸道自身免疫介导损伤的影响,如可卡因引起的中线破坏性病变。研究涉及兴奋剂相关的呼吸道中毒症候群的一个持续挑战是,吸毒者同时使用各种物质(包括吸烟)的情况非常普遍。现在,医疗保健提供者必须熟悉多种呼吸道中毒症候群以及与常见滥用兴奋剂相关的多种病理生理学,以便及时诊断和有效治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验